 Here are a few important reminders around requesting non-COVID/ non-flu AVP vaccines during this vaccine request window:
-
This vaccine request opportunity opens today, February 16th, and will remain open for 3 weeks. The last day to place an AVP vaccine request for this order cycle will be on Friday March 8th.
-
AVP vaccine requests will now take place in the IIS (in place of the survey used in previous years).
-
In order to receive an AVP order set in the IIS, your facility’s provider agreement and accountability must be up to date. This includes the submission of up-to-date inventory in the IIS, and up-to-date temperature log submission in Redcap. If your facility’s accountability is up to date, you will now have an AVP order set available to select in the IIS containing the vaccines prioritized on your AVP provider agreement.
- If your facility is not up to date on accountability, you will not see an order set in the IIS. Our team has reached out to facilities who are currently on hold to assist.
- You can become compliant at any point before orders close on March 8th to have an order set added. Reach out to us at WAAdultVaccines@doh.wa.gov and we can help get you back on track and eligible to request vaccine. Please don’t wait until the end of the request window if you intend to request vaccines.
- If you need assistance with Redcap, you can review any of our resources around navigating temperature log submission in Redcap: Step-by-Step Guide|Video | PDF
- The next AVP order request opportunity will be in September, so you may request a 6-month supply of vaccine. When placing your request, please keep in mind that AVP vaccines are a limited resource in high demand. Waste should be kept below 5%, so please order intentionally with regards to what your facility can administer.
- All non-COVID AVP vaccines can only be administered to uninsured adults 19+ years of age. Please keep in mind that Medicare/ Medicaid are considered insurance and individuals with coverage do not qualify for AVP.
- This is a vaccine request, not an order, and requests may be reduced to stay within the AVP’s available budget.
 We would like to remind providers that 2023-2024 COVID-19 vaccines are available to order through the Adult Vaccine Program.
COVID-19 Vaccines ordered through AVP can be administered to individuals who are either uninsured or underinsured—all other AVP vaccines can only be administered to uninsured individuals.
 COVID-19 vaccines are ordered through the IIS. There are currently three COVID-19 vaccines available to order:
- Pfizer prefilled syringes (fridge)
- Moderna single-dose vials (freezer, or a fridge for up to 30 days)
- Novavax multi-dose vials (5/vial, fridge)
The minimum order quantity for all three products is 10 doses.
 Although reported cases of mpox in the United States have significantly declined since the outbreak peak in the summer of 2022, small clusters have continued to occur. Severe mpox manifestations, including deaths, also continue to occur. Currently, only one in four of the approximately 2 million people eligible to receive JYNNEOS in the United States have received both doses. The Centers for Disease Control and Prevention (CDC) encourages providers to remain diligent about taking their patient’s sexual history and recommending the two-dose JYNNEOS vaccine to those who are eligible to help reduce the risk of continued mpox transmission.
In October 2023, the Advisory Committee on Immunization Practices recommended that people 18 years and older who are at risk or potential risk for mpox receive two doses of the JYNNEOS vaccine 28 days apart. The vaccine is safe and effective in preventing or minimizing the severity of mpox. CDC strongly urges clinicians, health departments, and community-based organizations to continue recommending the two dose JYNNEOS vaccine to eligible people and to encourage patients who have only received one dose to get the second dose to have the best protection. The vaccine is FDA-approved for prevention of mpox, regardless of the Clade.
For More Information:
Prevention | Mpox | Poxvirus | CDC
|
